UPDATE 1-FDA rejects Adamis' emergency drug for severe allergic reaction
June 06, 2016 at 07:44 AM EDT
June 6 (Reuters) - Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration rejected its emergency treatment for acute anaphylaxis, a severe allergic reaction, for the second time.
